Current management of melanoma: Benefits of surgical staging and adjuvant therapy

被引:26
作者
McMasters, KM
Swetter, SM
机构
[1] Univ Louisville, Div Surg Oncol, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
[2] Vet Affairs Palo Alto, Palo Alto, CA USA
[3] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
关键词
skin neoplasms; staging; sentinel lymph node; drug therapy; interferon-alpha;
D O I
10.1002/jso.10216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Issues regarding appropriate management of stage I to III melanoma are addressed. Accurate surgical staging is critical to identifying patients who can benefit from therapeutic lymph node dissection and adjuvant therapy. Patients with primary tumors greater than or equal to1 mm thick are appropriate candidates for sentinel lymph node biopsy, and node-positive patients benefit from therapeutic lymphadenectomy. Although the overall survival benefit of high-dose interferon has been questioned, the weight of evidence supports the use of adjuvant therapy in patients with stage IIB and III disease. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 55 条
[1]   Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma [J].
Albertini, JJ ;
Cruse, CW ;
Rapaport, D ;
Wells, K ;
Ross, M ;
DeConti, R ;
Berman, CG ;
Jared, K ;
Messina, J ;
Lyman, G ;
Glass, F ;
Fenske, N ;
Reintgen, DS .
ANNALS OF SURGERY, 1996, 223 (02) :217-224
[2]  
Balch Charles M., 1997, P1947
[3]   Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm) [J].
Balch, CM ;
Soong, SJ ;
Ross, MI ;
Urist, MM ;
Karakousis, CP ;
Temple, WJ ;
Mihm, MC ;
Barnhill, RL ;
Jewell, WR ;
Wanebo, HJ ;
Harrison, R .
ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (02) :87-97
[4]   Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger [J].
Balch, CM ;
Soong, SJ ;
Bartolucci, AA ;
Urist, MM ;
Karakousis, CP ;
Smith, TJ ;
Temple, WJ ;
Ross, MI ;
Jewell, WR ;
Mihm, MC ;
Barnhill, RL ;
Wanebo, HJ .
ANNALS OF SURGERY, 1996, 224 (03) :255-263
[5]   EFFICACY OF 2-CM SURGICAL MARGINS FOR INTERMEDIATE-THICKNESS MELANOMAS (1 TO 4 MM) - RESULTS OF A MULTIINSTITUTIONAL RANDOMIZED SURGICAL TRIAL [J].
BALCH, CM ;
URIST, MM ;
KARAKOUSIS, CP ;
SMITH, TJ ;
TEMPLE, WJ ;
DRZEWIECKI, K ;
JEWELL, WR ;
BARTOLUCCI, AA ;
MIHM, MC ;
BARNHILL, R ;
WANEBO, HJ .
ANNALS OF SURGERY, 1993, 218 (03) :262-269
[6]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[7]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[8]   Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system [J].
Buzaid, AC ;
Ross, MI ;
Balch, CM ;
Soong, SJ ;
McCarthy, WH ;
Tinoco, L ;
Mansfield, P ;
Lee, JE ;
Bedikian, A ;
Eton, O ;
Plager, C ;
Papadopoulos, N ;
Legha, SS ;
Benjamin, RS .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1039-1051
[9]   Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study [J].
Cameron, DA ;
Cornbleet, MC ;
Mackie, RM ;
Hunter, JAA ;
Gore, M ;
Hancock, B ;
Smyth, JF .
BRITISH JOURNAL OF CANCER, 2001, 84 (09) :1146-1149
[10]   Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial [J].
Cascinelli, N ;
Morabito, A ;
Santinami, M ;
MacKie, RM ;
Belli, F .
LANCET, 1998, 351 (9105) :793-796